News

Kurin, Inc. Provides Update on Litigation Activity

September 15, 2022

Kurin, Inc. Announces Full Scale Manufacturing of Push-button Needle

September 7, 2022

Kurin, Inc. Statement Regarding Patent Litigation

August 3, 2022

U.S. District Court Enters Judgment of No Infringement of Patent Asserted Against Kurin Inc. by Magnolia Medical Technologies, Inc.

June 16, 2022

Kurin, Inc. Announces Launch of Its Proprietary Push-button Needle System

February 23, 2022

Kurin, Inc. Announces Agreement with AllSpire Health GPO to Impact Contaminated Blood Cultures

January 18, 2022

Kurin, Inc. Reports Record Sales for Q4 and Total 2021 Revenues

January 11, 2022

Kurin, Inc. Reports Record Q3 Sales

October 18, 2021

Kurin, Inc. announces UK clinical study results showing significant decrease in blood culture contaminations with the Kurin Lock™

October 5, 2021

Kurin, Inc. Reports Record Sales Month

August 10, 2021

Kurin, Inc. announces results on Kurin® efficacy from Oishei Children’s Hospital with zero blood culture contaminations

July 21, 2021

Kurin, Inc. Announces Removal of Magnolia Patent Infringement Lawsuit Trial Date

March 23, 2021

Kurin, Inc. announces peer-reviewed publication on Kurin® efficacy from Central Texas Veterans Health Care System

January 19, 2021

Kurin, Inc. honored by MD Tech Review in annual listing of top Infection Control solutions

December 24, 2020

Kurin, Inc. Named to Inc.’s Inaugural Best in Business List in the Prosperous and Thriving Category

December 8, 2020

Kurin, Inc. Receives Allowance from United States Patent and Trademark Office of Additional Claims to its Innovative Blood Culture Collection Device.

November 17, 2020

Kurin, Inc. Reports Record Revenues

October 6, 2020

Kurin, Inc. Receives Supplier Horizon Award from Premier Inc.

September 29, 2020

Kurin, Inc. continues sales growth with record month.

July 29, 2020

Kurin, Inc. Announces Agreement with Intalere for Kurin Lock to impact contaminated blood cultures

June 30, 2020
1 2 3

ML-021 Rev A